Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Safety, efficacy and sleep effect of erenumab in chronic migraine: 12 months real life data

Laura Pilati,Angelo Torrente,Salvatore Di Marco,Giulia Notaro,Marika Romano,Salvatore Ferlisi,Filippo Brighina

JOURNAL OF THE NEUROLOGICAL SCIENCES（2021）

Cited 0|Views0
No score
Abstract
Erenumab, human monoclonal antibody directed against CGRPr, is first approved specific treatment for migraine. In this real-life study, we evaluate the efficacy and safety of erenumab associated with a multidisciplinary impact including sleep and circadian effect in 12 months treatment.
More
Translated text
Key words
chronic migraine,erenumab,sleep effect
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined